Value AD
CAN BE
ALTERNATIVE
INVESTMENT
FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)
FOR-FD-23-015
Janelle Fundersburg Grants Management Specialist
Funding Opportunity Number: FOR-FD-23-015
Opportunity Category: Discretionary
Expected Number of Awards: 30
CFDA Number(s): 93.103 -- Food and Drug Administration Research
Cost Sharing or Matching Requirement: No
Posted Date: Jul 27, 2022 12:00:00 AM EDT
Closing Date: N/A
Estimated Total Program Funding: 1000000
Eligible Applicants: State governments,County governments,Small businesses,Public housing authorities/Indian housing authorities,Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education,Special district governments,Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education,Native American tribal governments (Federally recognized),Native American tribal organizations (other than Federally recognized tribal governments),City or township governments,Independent school districts,Public and State controlled institutions of higher education,For profit organizations other than small businesses,Private institutions of higher education
Additional Information on Eligibility: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the HHS Grants Policy Statement, are not allowed.
Description:
The purpose of the FDA (R13) Scientific Conference Grant Program is to facilitate the provision of federal financial assistance in support of high-quality conferences and scientific meetings designed to research and investigate a topic clearly aligned with the FDA mission. The FDA recognizes the value of supporting high quality conferences and scientific meetings relevant to its mission and to the public health. A conference or scientific meeting is defined as a symposium, seminar, workshop, or any formal meeting, whether conducted face-to-face or virtually to exchange information and explore a defined subject, issue, or area of concern impacting the public's health within the scope of the FDA's mission. Permission to submit a conference grant application does not assure funding or funding at the level requested. FDA will not issue a conference grant award unless it can be issued before the conference start date.
